The American Heart Association and three other major medical organizations recently released new guidance establishing a framework to address cardiovascular disease, which accounts for approximately one in three female deaths in the United States and is projected to affect nearly six in ten women by 2050.
Cardiovascular disease remains the leading cause of mortality in women globally, yet medical guidelines have historically overlooked female biology. To combat rising rates, the American Heart Association partnered with the American Academy of Pediatrics, the American College of Obstetricians and Gynecologists, and the Society for Maternal-Fetal Medicine to issue joint updated guidance published in the journal Circulation.
The Female Life Stages Framework
The advisory establishes a framework tracking cardiovascular risk across four distinct hormonal stages: perimenarche, ovarian cycling, perimenopause, and postmenopause. “Estrogen, progesterone, and other sex hormones affect blood vessels, metabolism, and blood pressure throughout a woman’s life,” said May Bakir, M.D., F.A.C.C., a double-board-certified cardiologist and founder of InfiniteHeart Health, as reported by Prevention. Bakir said that biology was omitted from previous guidance.
During perimenarche, spanning ages 8 to 15, early first periods, irregular cycles, and heavy bleeding serve as initial markers of future cardiovascular risk, including high blood pressure and diabetes. Adolescence also introduces mental health vulnerabilities such as anxiety and depression that impact heart health.
Sadiya S. Khan, M.D., M.Sc., an expert volunteer for the American Heart Association and co-author of the guidance, told Prevention that women often feel they need to deal with menstrual symptoms rather than seeking medical evaluation.
The ovarian cycling stage, covering ages 15 to 44, brings hormone fluctuations and conditions like polyendocrine metabolic ovarian syndrome (PMOS, formerly PCOS), which links to cholesterol issues and insulin resistance. Pregnancy functions as a natural stress test during these years. Khan told Prevention that adverse pregnancy outcomes—such as gestational diabetes, hypertensive disorders, preterm birth, and small-for-gestational-age births—carry long-term implications for female heart health.
Physicians Evaluate Heart Disease Risk Using Sex-Specific Equations
- Life-Stage Screening: The new framework urges physicians to evaluate heart disease risk using sex-specific equations tailored to hormonal shifts at every age.
- Unified Care: Patients should share complete medical histories—including menstrual patterns and pregnancy outcomes—across pediatricians, gynecologists, and cardiologists to prevent missed warning signs.
Hormonal Shifts Increase Cardiovascular Disease Risk
Perimenopause, occurring roughly between ages 45 and 51, involves fluctuating estrogen levels and vasomotor symptoms like hot flashes and night sweats. These symptoms correlate with elevated heart disease risk and sleep disruption. Postmenopause, beginning after 12 consecutive months without a period, brings rising cholesterol, slower metabolism, and vascular remodeling.
During the postmenopausal stage, women face the highest statistical likelihood of experiencing cardiovascular events like heart attacks or strokes due to cumulative risks. Khan told Prevention that “clinicians and patients should discuss if hormone or non-hormonal therapies are what’s best for them.” Healthcare providers can assess this accumulated risk using sex-specific PREVENT equations highlighted in the guidance.
.jpg "Photo: heartfoundation.org.au")
Globally, regional health systems face similar challenges with female cardiovascular outcomes. The Heart Foundation reports that in Australia, coronary heart disease claims approximately 20 female lives a day, and women are less likely to undergo hospital treatment for heart attacks or angina compared to men.
The Australian Heart Foundation recommends that women aged 45 and over—or 30 and over for Aboriginal and/or Torres Strait Islander women—request regular Heart Health Checks from a general practitioner.
| Life Stage | Age Range | Primary Hormonal Markers | Key Cardiovascular Risk Factors |
|---|---|---|---|
| Perimenarche | 8–15 | Onset of menstruation | Early/irregular periods, adolescent anxiety, depression |
| Ovarian Cycling | 15–44 | Regular or fluctuating cycles | PMOS, gestational diabetes, hypertensive pregnancy disorders |
| Perimenopause | 45–51 | Declining estrogen | Hot flashes, night sweats, sleep disruption, psychosocial distress |
| Postmenopause | 51+ | Cessation of menstruation | Vascular remodeling, elevated cholesterol, metabolic slowdown |
Lifestyle Factors Complement Standard Heart Health Guidance
The guidance emphasizes that lifestyle factors—including a balanced diet, regular exercise, smoking cessation, and limited alcohol consumption—remain foundational, complementing the American Heart Association’s standard Life’s Essential Eight. “A unified global approach supports earlier risk identification, a holistic approach to health, and improves outcomes long-term,” Khan told Prevention.
References
- American Heart Association et al. Female Life Stages Framework for Cardiovascular Disease Prevention. Circulation.
- Heart Foundation. Women and Heart Health Guidance.
- Venditti V, Bleve E, Morano S, Filardi T. Gender-Related Factors in Medication Adherence for Metabolic and Cardiovascular Health. PubMed.
